Pharmagreen Biotech Inc
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue … Read more
Market Cap & Net Worth: Pharmagreen Biotech Inc (PHBI)
Pharmagreen Biotech Inc (PINK:PHBI) has a market capitalization of $1.06 Million ($1.06 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #36066 globally and #11731 in its home market, demonstrating a -11.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmagreen Biotech Inc's stock price $0.00 by its total outstanding shares 663645739 (663.65 Million).
Pharmagreen Biotech Inc Market Cap History: 2015 to 2025
Pharmagreen Biotech Inc's market capitalization history from 2015 to 2025. Data shows change from $305.28 Million to $1.06 Million (-45.01% CAGR).
Pharmagreen Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmagreen Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
350.31x
Pharmagreen Biotech Inc's market cap is 350.31 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $398.19K | $3.00K | -$569.00K | 132.82x | N/A |
| 2024 | $1.19 Million | $3.41K | -$1.00 Million | 350.31x | N/A |
Competitor Companies of PHBI by Market Capitalization
Companies near Pharmagreen Biotech Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Pharmagreen Biotech Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Pharmagreen Biotech Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Pharmagreen Biotech Inc's market cap moved from $305.28 Million to $ 1.06 Million, with a yearly change of -45.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.06 Million | -11.11% |
| 2024 | $1.19 Million | +200.00% |
| 2023 | $398.19K | -80.00% |
| 2022 | $1.99 Million | -84.21% |
| 2021 | $12.61 Million | +72.73% |
| 2020 | $7.30 Million | -98.43% |
| 2019 | $464.55 Million | -58.82% |
| 2018 | $1.13 Billion | +37.10% |
| 2017 | $822.92 Million | +463.64% |
| 2016 | $146.00 Million | -52.17% |
| 2015 | $305.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pharmagreen Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Million USD |
| MoneyControl | $1.06 Million USD |
| MarketWatch | $1.06 Million USD |
| marketcap.company | $1.06 Million USD |
| Reuters | $1.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.